Pishoy Gouda, Elie Ganni, Peter Chung, Varinder Kaur Randhawa, Guillaume Marquis-Gravel, Robert Avram, Justin A Ezekowitz, Abhinav Sharma
Purpose of Review: With the rising cost of cardiovascular clinical trials, there is interest in determining whether new technologies can increase cost effectiveness. This review focuses on current and potential uses of voice-based technologies, including virtual assistants, in cardiovascular clinical trials. Recent Findings: Numerous potential uses for voice-based technologies have begun to emerge within cardiovascular medicine. Voice biomarkers, subtle changes in speech parameters, have emerged as a potential tool to diagnose and monitor many cardiovascular conditions, including heart failure, coronary artery disease, and pulmonary hypertension...
2021: Current Cardiovascular Risk Reports